This website uses cookies
We use cookies to personalize content and ads, to provide social media features and to analyze our traffic.
We do not share your personal information. We do share data regarding your use of our site with our social media, advertising and analytics partners who may combine it with other information that you've provided to them or that they've collected from your use of their services.
An analysis evaluating the quantitative role of federally funded cancer clinical trials vs those funded by industry sponsors found that early-phase, multimodality, dose de-escalation, rare cancer, and child-focused drug and biological agent clinical trials were more likely to be conducted by federally sponsored research groups.
Since January, Trump has blitzed US funding for research institutions and universities, and overseen mass layoffs of scientists at federal agencies. His cuts have raised the possibility of the United States losing its position as the world leader in research.
Federal support for scientific inquiry, once considered a pillar of the nation’s innovation and global competitiveness, is facing unprecedented disruption.
Nearly two months after the federal government froze over half a million dollars in research funding to UCLA, the National Institutes of Health has temporarily reinstated their suspended grants Tuesday – abiding by a federal judge’s Monday ruling.
According to the AACR Cancer Progress Report 2025, due to the budget cuts across all federal health agencies—coupled with grant delays, canceled clinical trials, mass layoffs throughout the research workforce, and political interference—the cancer research and clinical care community is “facing its most serious funding crisis in a generation.”
The Trump administration has given notice that political appointees, rather than scientists, will ultimately decide who gets grant money from the world’s largest biomedical research funder — the federal government’s National Institutes of Health.
When Geza Kogler, a former professor at Kennesaw State University, lost his National Institutes of Health grant, he didn’t just lose funding; he lost a program he believed in and, quite possibly, his career in academia.
On Thursday evening, dozens of researchers hosted a science fair at UCLA aimed at showcasing the work that’s been suspended by the Trump administration.
A nonpartisan research institute estimated how the Rochester area's labor market would be impacted if significant cuts to the National Institutes of Health's budget come to pass.
Gov. Tony Evers, during 2025 the Year of the Kid, sent a letter to every member of Wisconsin’s Congressional delegation urging bipartisan opposition to President Donald Trump’s proposed budget and calling on Congress to reject the president’s reckless cuts to critical programs and services that support Wisconsin’s kids, students, schools, and families.
Top Democratic lawmakers are accusing the Trump administration of blocking billions of dollars in federal funding that they say is at risk of lapsing at the end of the month.
Democratic-led states that sued to block the cuts kept much of their funding, while Republican-led states lost the bulk of theirs, according to a new analysis from health research organization KFF.
A federal judge in Boston sided with the Ivy League school on Wednesday, ruling the cuts amounted to illegal retaliation for Harvard’s rejection of White House demands for changes to its governance and policies.
Since 1946, the NIH has doled out funds based mainly on merits established by a scientific review process that ranks each proposal based on innovation, importance and feasibility.
Over the next decade, the Congressional Budget Office estimates a 10-year reduction of more than $1 trillion for health care. Iowa faces an expected $9.5 billion reduction,
From GPS to GLP-1 drugs, game-changing ideas often start with federal research dollars funding wacky experiments. Slashing it risks the trillion-dollar industries of tomorrow.
It is the first public university in the state to confirm employee cuts in response to President Donald Trump’s administration canceling many awards for advancing science.
The grants, funding 195 different projects, were determined by the Trump administration to focus too narrowly on sexual or racial minority groups — drawing outrage from some holdover officials from the Biden administration and contributing to at least one high-profile resignation this week.
In the shadow of Independence Hall, the symbol of liberty and American advancement, cancer survivors and advocates are fighting to save medical research from Mr. Trump's proposed cutbacks.